Valitor
company
About
Valitor has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacological properties..
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $2.52M
- Industries
- Biotechnology,Developer Tools,Medical,Therapeutics
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Their technology platform can be broadly applied to improve the pharmacological properties of many protein drugs that are currently approved or under development. They currently have three development pipelines in the fields of dermatology, ophthalmology, and orthopedics that highlight the capabilities of their novel drug products.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.52M
Valitor has raised a total of
$2.52M
in funding over 2 rounds. Their latest funding was raised on
Sep 20, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 20, 2018 | Series A | $2.52M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Valitor is funded by 3 investors.
Z-Gen Capital
and Phaenomena West Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
